IGF1 and cancer: In vivo studies suggest that carcinogenesis and cancer progression are influenced by germ line variation of genes encoding signalling molecules in the GH-IGF-1 axis and these mutations are often associated with genetic manipulations [144] and low IGF-1 levels; thus, tumour growth is influenced by IGF-1 physiology [145].